CompletedNot Applicable

Outcomes of Critically Ill Patients With Hematologic Malignancies

144 participantsStarted 2009-01-01

Plain-language summary

The investigators sought to report the outcomes of patients with haematological malignancies admitted to the intensive care units and to define pre-intensive care units prognostic factors for in-hospital all-cause mortality. In this retrospective, single-center study, all patients with haematologic malignancies admitted to intensive care units between 2009 and 2019 were included. The primary outcome was in-hospital mortality.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosis of HM on admission or discharge from the ICU Exclusion Criteria: * patients under 18 years of age patients who were completely cured of malignancy for more than five years patients admitted to the ICU during the COVID-19 pandemic

What they're measuring

mortality

Timeframe: 30 day

Trial details

NCT IDNCT06410066

SponsorSoroka University Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-31

View on ClinicalTrials.gov More Hematologic Malignancy trials